key: cord-1004320-vjsh7mth
authors: Bhoyar, Rahul C.; Jain, Abhinav; Sehgal, Paras; Divakar, Mohit Kumar; Sharma, Disha; Imran, Mohamed; Jolly, Bani; Ranjan, Gyan; Rophina, Mercy; Sharma, Sumit; Siwach, Sanjay; Pandhare, Kavita; Sahoo, Swayamprabha; Sahoo, Maheswata; Nayak, Ananya; Mohanty, Jatindra Nath; Das, Jayashankar; Bhandari, Sudhir; Mathur, Sandeep K; Kumar, Anshul; Sahlot, Rahul; Rojarani, Pallavali; Lakshmi, Juturu Vijaya; Surekha, Araveti; Sekhar, Pulala Chandra; Mahajan, Shelly; Masih, Shet; Singh, Pawan; Kumar, Vipin; Jose, Blessy; Mahajan, Vidur; Gupta, Vivek; Gupta, Rakesh; Arumugam, Prabhakar; Singh, Anjali; Nandy, Ananya; Raghavendran, P.V.; Jha, Rakesh Mohan; Kumari, Anupama; Gandotra, Sheetal; Rao, Vivek; Faruq, Mohammed; Kumar, Sanjeev; Betsy Reshma, G; Narendra Varma, G; Roy, Shuvra Shekhar; Sengupta, Antara; Chattopadhyay, Sabyasachi; Singhal, Khushboo; Pradhan, Shalini; Jha, Diksha; Naushin, Salwa; Wadhwa, Saruchi; Tyagi, Nishu; Poojary, Mukta; Scaria, Vinod; Sivasubbu, Sridhar
title: High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing
date: 2020-08-10
journal: bioRxiv
DOI: 10.1101/2020.08.10.242677
sha: 4ae2f596199dc5eadf7f7d8cb8c2a1796c24bdb9
doc_id: 1004320
cord_uid: vjsh7mth

The rapid emergence of coronavirus disease 2019 (COVID-19) as a global pandemic affecting millions of individuals globally has necessitated sensitive and high-throughput approaches for the diagnosis, surveillance and for determining the genetic epidemiology of SARS-CoV-2. In the present study, we used the COVIDSeq protocol, which involves multiplex-PCR, barcoding and sequencing of samples for high-throughput detection and deciphering the genetic epidemiology of SARS-CoV-2. We used the approach on 752 clinical samples in duplicates, amounting to a total of 1536 samples which could be sequenced on a single S4 sequencing flow cell on NovaSeq 6000. Our analysis suggests a high concordance between technical duplicates and a high concordance of detection of SARS-CoV-2 between the COVIDSeq as well as RT-PCR approaches. An in-depth analysis revealed a total of six samples in which COVIDSeq detected SARS-CoV-2 in high confidence which were negative in RT-PCR. Additionally, the assay could detect SARS-CoV-2 in 21 samples and 16 samples which were classified inconclusive and pan-sarbeco positive respectively suggesting that COVIDSeq could be used as a confirmatory test. The sequencing approach also enabled insights into the evolution and genetic epidemiology of the SARS-CoV-2 samples. The samples were classified into a total of 3 clades. This study reports two lineages B.1.112 and B.1.99 for the first time in India. This study also revealed 1,143 unique single nucleotide variants and added a total of 73 novel variants identified for the first time. To the best of our knowledge, this is the first report of the COVIDSeq approach for detection and genetic epidemiology of SARS-CoV-2. Our analysis suggests that COVIDSeq could be a potential high sensitivity assay for detection of SARS-CoV-2, with an additional advantage of enabling genetic epidemiology of SARS-CoV-2.

Coronavirus Disease 2019 has emerged as a global epidemic affecting millions of individuals globally and imposes a huge burden on the socio-economic welfare and healthcare systems of nations. At present the need for assays for rapid detection for diagnosis and surveillance, understanding the genetic epidemiology and evolution of the virus would be central for managing the spread of the epidemic (J. Meredith et al., 2020) . The advantage of quick sequencing of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome led to the development of polymerase chain reaction (PCR) based diagnostic assays that leveraged rapid identification of infected individuals to get fast medical support or quantization essential to both patient management and incidence tracking (Wu et al., 2020) . Identification of early imported cases in France helped to prevent immediate secondary transmission (Bernard Stoecklin et al., 2020) . Singapore's enhanced surveillance and containment strategy also led to the suppressed expansion of SARS-CoV-2 (de Lusignan et al.,

Research and Surveillance Centre (RSC) have rapidly expanded their national surveillance system to combat SARS-CoV-2 (Ng et al., 2020) . Coupled with a highly accurate and high-throughput method of detection, this approach will become more effective in dealing with COVID-19.

A number of approaches have been widely used for the detection of SARS-CoV-2 from clinical samples. Some of these approaches have also been adapted to enable higher throughputs. These methods are majorly subdivided into antigen-antibody based serological assays, nucleic acid based amplification assays and sequencing based assays. While serological assays are rapid detection tests, they have low sensitivity and specificity (Döhla et al., 2020) . Nucleic acid based amplification such as Real-Time PCR (RT-PCR) has been the gold standard in detection and diagnosis, but a negative RT-PCR does not eliminate the possibility of infection in clinically suspected cases (Wang et al., 2020) . Such results should be carefully interpreted to avoid false negative reporting (Kucirka et al., 2020) . Moreover, these tests have been developed for diagnostic purposes and do not provide much information on the nature of the virus, its 4 of 25 genetic information and evolutionary pattern. In this regard, recently developed Next generation sequencing based methods are potentially a good alternative for detection of SARS-CoV-2 ('First NGS-based COVID-19 diagnostic', 2020).

The rapid advancement of Next generation sequencing technology and analysis methods has enabled understanding the genetic makeup of SARS-CoV-2 and interpreting its evolutionary epidemiology. Viral RNA sequencing from the initial cluster of cases deciphered the full genome sequence of SARS-CoV-2 (Zhu et al., 2020) . This led to other sequencing based studies for detailed genomic characterization of the virus (R. . Combined genetic and epidemiological studies have been suggested to provide insights into spread of the infection, evolutionary patterns and genetic diversity of the virus (J. Meredith et al., 2020) , for further assisting in effective management and preventive measures. Genomic surveillance coupled with agent-based modelling in Australia has been observed as an excellent approach to investigate and regulate COVID-19 transmission (Rockett et al., 2020) .

Towards these efforts, several openly available databases have also been developed such as the Global Initiative on Sharing All Influenza Data (GISAID) that facilitates rapid and open sharing of SARS-CoV-2 genome sequences (Shu and McCauley, 2017) .

Thus, along with detection, sequencing based methods may also provide an added advantage of understanding the genetic epidemiology of the outbreak.

In the present study, we describe the application of the COVIDSeq protocol recently approved by the US FDA for clinical use. This protocol envisages high-throughput detection and genetic epidemiology of SARS-CoV-2 isolates using a multiplex PCR amplicon based enrichment followed by barcoding with a throughput of 1536 samples in a single sequencing run using NovaSeq S4 flow cell. Our analysis suggests that COVIDSeq protocol could be a sensitive approach for detection with additional insights offered through genetic epidemiology with respect to the genetic lineages. To the best of our knowledge this is the first real-life evaluation of COVIDSeq protocol.

The study was approved by the Institutional Human Ethics Committee (IHEC No. Dated CSIR-IGIB/IHEC/2020-21/01).

Samples from nasal, nasopharyngeal, and oropharyngeal swabs were obtained according to the standard protocol and collected in 3 ml sterile viral transport medium (VTM) tube or 1ml of TRIzol reagent (Invitrogen). All the samples were transported to the laboratory at a cold temperature (2-8°C) within 72 hours post collection, and stored at -80°C till further used.

RNA extraction was carried out in a pre-amplification environment with Biosafety level 2 tubes. An equal amount of isopropanol was added to the tubes containing the RNA.

Contents of the tubes were mixed by inverting the tubes several times and tubes were 6 of 25 incubated for 10 minutes on ice followed by centrifugation for 10 minutes at 12,000 RPM at 4°C. The supernatant was discarded and the RNA pellet was dissolved in 30 μl of RNase-free water after 2 ethanol washes. TURBO DNase (Ambion, Applied Biosystems) treatment was given to the isolated RNA to remove genomic DNA contamination in the samples followed by RNA purification using the phenol/chloroform method.

To detect SARS-CoV-2 viral infection, one-step Real-Time PCR assay was performed using STANDARD M nCoV Real-Time detection kit (SD Biosensor, Korea), targeting the nCoV2 specific ORF1ab (RdRp) and pan-sarbeco specific E genes on LightCycler® 480

System (Roche) and ABI 7500 Fast DX (Applied Biosystems) as per the manufacturer's instructions.

The libraries were prepared using Illumina COVIDSeq protocol (Illumina Inc, USA). The first strand synthesis was carried out in Biosafety level 2 (BSL-2) plus environment following standard protocols. The synthesized cDNA was amplified using a multiplex polymerase chain reaction (PCR) protocol, producing 98 amplicons across the SARS- 

The raw data generated in binary base call (BCL) format from NovaSeq 6000 was For in-depth analysis, we additionally analysed the data using a custom pipeline. This included demultiplexing the raw data to FASTQ files using bcl2fastq (v2.20) followed by quality assessment of the FASTQ files using Trimmomatic (v0.39) (Bolger, Lohse and Usadel, 2014 ). An average base quality of Q30 and read length cut-off of 30 bps were used for trimming, apart from the adapter sequences. We followed a recently published protocol to perform reference-based assembly (Poojary et al., 2019) . As per protocol, the trimmed reads were aligned to the human reference genome (GRCh38 / hg38) and SARS-CoV-2 Wuhan-Hu-1 reference genome (NC_045512.2) using HISAT2-2.1 (Kim, Langmead and Salzberg, 2015) . The reads mapped to hg38 were further discarded and the unaligned reads were extracted using samtools (v 1.10) (Li et al., 2009) . The unaligned reads were further mapped to the Wuhan Hu-1 genome and the alignment statistics were evaluated (Wu et al., 2020) . (Shen et al., 2016) were used to generate the consensus sequence. We have also evaluated the correlation coefficient with p-value < 0.01 between the duplicates total reads and genome coverage.

The variants were systematically annotated using ANNOVAR (Wang, Li and Hakonarson, 2010) . Annotations on genomic loci and functional consequences of the protein were retrieved from RefSeq. Custom databases were created for annotations on functional consequences, potential immune epitopes, protein domains and evolutionary conservation scores. Genomic loci associated with common error prone sites and diagnostic primer/probe regions were manually curated and were systematically converted to datatables compatible with ANNOVAR for added annotation options. (Hadfield et al., 2018) till August 08, 2020 was also used for comparison.

A total of 495 samples that had at least 99% genome coverage were considered for this analysis, along with the dataset of SARS-CoV-2 genomes from India deposited in GISAID. The sample names and the name of the originating and submitting institutions are listed in Supplementary Table 1b . We followed a previously described protocol for phylogenetic clustering (Jolly and Scaria, 2020 under review). A total of 26 COVIDSeq genomes having Ns > 5% were removed from the analysis. Genomes from GISAID having Ns > 5% and ambiguous dates of sample collection were also excluded from the analysis. The phylogenetic network was built using the analysis protocol for SARS-CoV-2 genomes provided by Nextstrain (Hadfield et al., 2018) . The genome sequences were aligned using MAFFT to the reference genome and problematic variant positions were masked (Katoh and Toh, 2008) . A raw phylogenetic tree was constructed using IQTREE 9 of 25 and the raw tree was refined to construct a molecular-clock phylogeny, infer mutations, and identify clades (Nguyen et al., 2015) . The resulting phylogenetic tree was viewed using Auspice, an interactive visualization web-application provided by Nextstrain.

Lineages were also assigned to the genomes using the Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) package (Rambaut et al., 2020) . The phylogenetic distribution of the lineages was visualized and annotated using iToL (Letunic and Bork, 2016) .

Initially, all the samples underwent RT-PCR based screening for the presence of SARS-CoV-2 RNA. Out of these 752 samples, 655 (87.1%) samples were RT-PCR positive, 43 (5.7%) were pan-sarbeco, 35 (4.6%) were inconclusive and 19 (2.5%) were negative. We compared the sample type (e.g. positive, pan-sarbeco, inconclusive and negative) WGS output and calculated percent of genome covered, sensitivity, specificity, accuracy, precision and gain of detection rate. The methodology adopted in this study has been represented in Figure 1 . 

The sample panel consisted of a total of 752 samples. For further genome assembly and variant calling, the alignment files were merged and variants were called using VarScan. Only 495 samples that had at least 99% of the genome covered were considered for variant call.

The analysis identified a total of 1,143 unique variants. 73 genetic variants were found to be novel in comparison with other Indian and global genome data and were reported for the first time. The median for the number of variants called were 12. The distribution of the variants per genome is summarised in Figure 4A . Of the 1,143 unique variants, a total of 1,104 variants were in the exonic region and 39 were in the downstream or upstream region. Of the 1,104 exonic variants, 639 variants were non-synonymous while 452 were synonymous. A total of 13 were found to be stopgain. The variant annotation data is summarized in Figure 4B . Consistently, the samples have over 5% of the genomic region covered in the COVIDSeq protocol suggesting that the protocol could provide for a potentially more sensitive detection assay compared to RT-PCR.

Since the RNA samples were derived from multiple protocols for RNA extraction, we could also get an insight into the compatibility of the protocols with the COVIDSeq test.

Of the samples which were SARS-CoV-2 positive on RT-PCR, 182 samples were processed 

A number of high-throughput approaches have recently been employed for the detection as well as sequencing of SARS-CoV-2, while RT-PCR based approaches are widely considered as the gold-standard for detection. These include shotgun approaches (Harilal et al., 2020) , capture based (Wen et al., 2020; Xiao et al., 2020) as well as amplicon based (Baker et al., 2020) approaches followed by Next Generation

Sequencing. Typically the multiplex barcoded library sequencing has been implemented for sample numbers less than 96. A number of approaches have been suggested to increase the throughput of sequencing using barcoded libraries (Palmieri et al., 2020; Schmid-Burgk et al., 2020) . There is a paucity of data on higher order multiplex barcoding and sequencing approaches in clinical samples.

In the present report, we evaluated the COVIDSeq approach for high-throughput detection of SARS-CoV-2 which uses multiplex PCR followed by barcoded libraries and sequencing on a next-generation sequencing platform which envisages sequencing 1536 samples per flow cell. We analysed 752 clinical samples in technical duplicates.

Our analysis suggests a high concordance between technical duplicates and a high concordance of detection of SARS-CoV-2 between the COVIDSeq as well as RT-PCR approaches. Our comparative analysis of SARS-CoV-2 detection with RT-PCR and COVIDSeq test showed that COVIDSeq test outperformed with increased sensitivity, precision and accuracy. COVIDSeq protocol detected SARS-CoV-2 in samples previously categorised as inconclusive (21/35), pan-sarbeco (16/43) and negative (6/19) using RT-PCR assays suggesting a higher sensitivity of the sequencing based assay compared to RT-PCR. This corresponded to an additional 43/97 samples and a potential gain of 5.71% of samples of the whole dataset and 44.33% of the samples which were considered inconclusive (N=97), suggesting that the sequencing approach could be used as a potential orthogonal approach to confirm cases which are doubtful or inconclusive in RT-PCR. Notwithstanding the advantage, 16 samples which were annotated positive in RT-PCR were missed in the COVIDSeq approach. Our analysis also suggests the protocol is compatible with different approaches for RNA isolation 19 of 25 suggesting a wider applicability in clinical settings where pooling from different labs becomes inevitable.

The COVIDSeq approach additionally provided insights into the genetic epidemiology and evolution of the SARS-CoV-2 isolates. Phylogenetic analysis could be performed for a significantly large number of genomes which gave insights into the prevalent lineage/clades of the virus (Langat et al., 2017; Michie et al., 2020; Shakya et al., 2020) .

This analysis also reports two lineages B.1.112 and B.1.99 for the first time in India.

Furthermore, a total of 1,143 unique variants were contributed by this analysis to the global repertoire of genetic variants. As expected, a significant number of variants were non-synonymous in nature (Kryazhimskiy, Bazykin and Dushoff, 2008; Tang et al., 2020) . The present analysis adds a total of 73 novel variants identified for the first time in genomes. Apart from the throughput of sample analysis, the COVIDSeq approach is also remarkable in terms of speed, with a sequencing time of 11 hours and analysis timeline of 6 hours. Given that the NovaSeq 6000 sequencer used in the present study can handle two S4 flow cells in parallel, this could be potentially scaled to a throughput of 1536x2 samples that can be handled in parallel.

In conclusion, our analysis suggests that COVIDSeq is a high-throughput sequencing based approach which is sensitive for detection of SARS-CoV-2. In addition, COVIDSeq has an additional advantage of enabling genetic epidemiology of SARS-CoV-2.

CoronaHiT: large scale multiplexing of SARS-CoV-2 genomes using Nanopore sequencing

First cases of coronavirus disease

Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Trimmomatic: a flexible trimmer for Illumina sequence data

Computational Analysis and Phylogenetic clustering of SARS-nCov-2 genomes

Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity', Public health

First NGS-based COVID-19 diagnostic' (2020) Nature biotechnology

Nextstrain: real-time tracking of pathogen evolution

SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission

Recent developments in the MAFFT multiple sequence alignment program

HISAT: a fast spliced aligner with low memory requirements

VarScan: variant detection in massively parallel sequencing of individual and pooled samples

Natural selection for nucleotide usage at synonymous and nonsynonymous sites in influenza A virus genes

Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

Genome-wide evolutionary dynamics of influenza B viruses on a global scale

Interactive tree of life (iTOL) v3: an online tool for the

The Sequence Alignment/Map format and SAMtools

Genomic Epidemiology of SARS-CoV-2 in Guangdong Province

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England', JMIR public health and surveillance

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study', The Lancet infectious diseases

Genome-Scale Phylogeny and Evolutionary Analysis of Ross River Virus Reveals Periodic Sweeps of Lineage Dominance in Western Australia

IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies

Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore

REMBRANDT: A high-throughput barcoded sequencing approach for COVID-19 screening

Computational Protocol for Assembly and Analysis of SARS-nCoV-2 Genomes

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology', Nature microbiology

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling', Nature medicine

LAMP-Seq: Population-Scale COVID-19 Diagnostics Using Combinatorial Barcoding

Standardized phylogenetic and molecular evolutionary analysis applied to species across the microbial tree of life

SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation

GISAID: Global initiative on sharing all influenza data -from vision to reality', Euro surveillance: bulletin Europeen sur les maladies transmissibles =

On the origin and continuing evolution of SARS-CoV-2

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak

High-coverage SARS-CoV-2 genome sequences acquired by target capture sequencing

A new coronavirus associated with human respiratory disease in China

Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples

A Novel Coronavirus from Patients with Pneumonia in China

Authors declare no conflicts of interest.

Raw datasets are available at NCBI short Read Archive with Project ID PRJNA655577.The replicate datasets are accessible with IDs SUB7891477 and SUB7864921.

Supplementary